That's going to be a challenge. There is also the challenge of having to re-educate people. Health providers, people who've been out working for decades, were not taught how to report adverse events. We knew it was part of our review of the patient, whether it be lack of efficacy or an adverse event. We knew it was part of the risk of drug therapy, but taking the next step, which was to report this to a body, whatever body that may be, was not included.
I think we need to start looking at that and return to our universities and get our students to do this. Their practicums need to include this in their training. We've been remiss in that.
We have people who have been involved with clinical trials. They have that knowledge and skill. They do it regularly, because it's part and parcel of a clinical trial. But the great majority of practitioners are not involved in that. It has to become the day-to-day routine. If we had an electronic means of transmitting the information from all practitioners in the country, I think we would have an amazing array of information, which we then would have to have someone analyze, obviously, to make it useful for the practitioners.